The radiofrequency balloon catheter market is anticipated to exhibit growth at a 5.5% CAGR over the assessment period, surpassing US$ 50 Billion in 2022. The rising incidence of atrial fibrillation and pulmonary vein isolation is expected to underpin demand in the market. Additionally, radiofrequency balloon catheters have been proven to be safe and effective, which is propelling their adoption in the healthcare sector.
| Report Attribute | Details |
|---|---|
| Radiofrequency Balloon Catheter Market Size (2022) | US$ 50 Billion |
| Radiofrequency Balloon Catheter Market Projected Growth Rate (2022 to 2032) | 5.5% |
Manufacturers are currently developing radiofrequency balloon catheters; the plans for which are in the pipeline. For instance, Biosense Webster, Inc. has developed a multi-electrode radiofrequency balloon catheter for the treatment of symptomatic paroxysmal atrial fibrillation. Such developments are expected to bode well for the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising cases of atrial fibrillation are placing a critical burden on the healthcare sector. According to the CDC, in 2030, an estimated 12.1 million people will suffer from atrial fibrillation in the USA
Applications of radiofrequency balloon catheters are expected to increase for the treatment of atrial fibrillation and pulmonary vein isolation. These devices are used to examine atrial fibrillation and are designed to optimize efficacy and safety and reduce treatment time. The radiofrequency energy of the radiofrequency balloon catheter helps the catheters move from the femoral vein to the left atrium and assists in examining atrial fibrillation.
With the advancement of technology and increasing investments in the healthcare sector, the adoption of radiofrequency balloon catheters will rise. In addition to this, the launch of new and advanced radiofrequency balloon catheters will also foster growth in the radiofrequency balloon catheter market
There are certain factors that may hamper the growth of the radiofrequency balloon catheter market. Radiofrequency balloon catheters require a skilled trainer to know and use the devices well since they require more functions to operate the devices.
A lack of skilled professionals and well-trained healthcare professionals may impede the growth of the radiofrequency balloon catheter market. Further, the rate of reproduction is less as compared to a cryoballoon.
The cost of the radiofrequency balloon catheter is high in comparison to other catheters. These factors are expected to limit sales in the market over the forecast period.
Principal Consultant
North America is predicted to witness growth at a considerable pace over the forecast period. Due to the rising adoption of new and advanced technologies, manufacturers are launching technologically-advanced radiofrequency balloon catheters.
The USA and Canada have recorded an increase in the incidence of chronic disorders owing to sedentary lifestyles. Additionally, the rising number of patients undergoing surgeries, and growing awareness of minimally invasive surgeries are factors that are anticipated to propel sales.
According to CDC, heart diseases account for one in every four deaths in the USA Each year there are about 659,000 deaths related to cardiovascular diseases in the USA Obesity, poor lifestyle habits such as a poor diet, physical inactivity, excessive alcohol intake, smoking, hypertension, and high cholesterol levels are some factors that cause cardiovascular diseases. About 50% of Americans exhibit at least one of these behavioral risk factors.
According to the IHME report published in 2017, ischemic heart disease was the leading cause of death and disability in Canada. Therefore, the rising incidence of peripheral artery disease, occlusions in blood vessels, and awareness of minimally invasive surgeries may boost demand for catheters in Canada.
Growing awareness among individuals about heart diseases, early diagnosis, and minimally invasive treatment options will underscore the requirement for radiofrequency balloon catheters across the Asia Pacific.
Significant growth can also be noted in the Japan radiofrequency balloon catheter market. This is owing to increased interest and investment in research and development of new healthcare facilities and treatment options. In addition to this, rising cases of atrial fibrillation in the country will augment the adoption of radiofrequency balloon catheters in the forthcoming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading players operating in the radiofrequency balloon catheter market are Medtronic, and Biosense Webster, Inc.
These players are investing in research and development activities to incorporate the latest and advanced technologies to improve their product portfolios.
| Report Attribute | Details |
|---|---|
| Growth Rate (2022 to 2032) | 5.5% CAGR |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Radiofrequency balloon catheters are used to examine atrial fibrillation. Increasing investments in the expansion of the healthcare infrastructure across emerging economies will drive sales in the market over the assessment period.
Higher costs of production and a dearth of skilled professionals who are well-versed in the functions of the product are some factors that might hinder the growth in the market.
Key players in the radiofrequency balloon market include Medtronic and Biosense Webster Inc.
1. Executive Summary | Radiofrequency Balloon Catheter Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2022 to 2032
5.3.1. Chronic Haemorrhagic Radiation Proctitis
5.3.2. Malignant Biliary Strictures
5.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostics Laboratories
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. United Kingdom
8.2.1.2. Canada
8.2.2. By Indication
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Indication
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Indication
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Indication
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Indication
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Indication
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. Rest of Asia Pacific
11.2.2. By Indication
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Indication
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Indication
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Indication
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. United Kingdom
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Indication
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Indication
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Indication
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Indication
13.4.2.2. By End User
13.5. Rest of Latin America
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Indication
13.5.2.2. By End User
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Indication
13.6.2.2. By End User
13.7. United Kingdom
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Indication
13.7.2.2. By End User
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Indication
13.8.2.2. By End User
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Indication
13.9.2.2. By End User
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Indication
13.10.2.2. By End User
13.11. Rest of Europe
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Indication
13.11.2.2. By End User
13.12. China
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Indication
13.12.2.2. By End User
13.13. Japan
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Indication
13.13.2.2. By End User
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Indication
13.14.2.2. By End User
13.15. Malaysia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Indication
13.15.2.2. By End User
13.16. Singapore
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Indication
13.16.2.2. By End User
13.17. Australia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Indication
13.17.2.2. By End User
13.18. Rest of Asia Pacific
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Indication
13.18.2.2. By End User
13.19. GCC Countries
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Indication
13.19.2.2. By End User
13.20. South Africa
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Indication
13.20.2.2. By End User
13.21. Israel
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2021
13.21.2.1. By Indication
13.21.2.2. By End User
13.22. Rest of the Middle East and Africa
13.22.1. Pricing Analysis
13.22.2. Market Share Analysis, 2021
13.22.2.1. By Indication
13.22.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Indication
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Medtronic
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Biosense Webster
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Koninklijke Philips
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Abbott Laboratories
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Boston Scientific Corporation
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. B. Braun Melsungen
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Terumo Corporation
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Teleflex Incorporated
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Nordson Corporation.
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Becton, Dickinson, and Company
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Radiofrequency Balloon Catheter Market
